novo nordisk zepbound - Search News

Order byBest matchMost fresh

News

Zepbound beats Wegovy for weight loss

Eli Lilly's Zepbound outperforms Novo Nordisk's Wegovy for weight loss in trial

Eli Lilly said on Sunday its drug Zepbound was superior to Novo Nordisk's Wegovy across five weight-loss targets such as reducing waist circumference, citing data from a head-to-head trial. The data is the first head-to-head trial comparing the wildly popular medicines,

Continue reading

· 3d · on MSN

Novo Nordisk Tumbles as Lilly's Zepbound Shows Greater Weight Loss in Trial

· 4d · on MSN

Zepbound beats Wegovy for weight loss in first head-to-head trial of blockbuster drugs

3d

Zepbound trims more belly fat than Wegovy, study shows

The obesity drug helped people trim about two inches more off their waists than Wegovy in the first head-to-head study of the ...

1don MSN

Novo Nordisk strikes $2.2 billion deal with Septerna to develop new obesity treatments

Novo Nordisk has struck a collaboration and licensing deal with U.S. biotech Septerna to develop oral small molecule ...

MarketBeat on MSN13h

Is It Time to Buy the Dip in Novo Nordisk Stock?

CompanyOverview|NYSE:NVO] Despite a double beat in its quarterly earnings on May 7, Novo Nordisk A/S (NYSE: NVO) stock is ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results